Glutathione and related gamma-glutamyl compounds, including glutamine, have a number of significant functions in amino acid and protein metabolism. We propose continuation of research on the structure-function relationships and on the mechanisms of catalysis and regulation of a group of closely related enzymes that are involved in the metabolism and function of glutathione. These enzymes include gamma-glutamylcysteine synthetase, glutathione synthetase, gamma-glutamyl transpeptidase, gamma- glutamyl cyclotransferase, 5-oxoprolinase, and glutamine- dependent carbamyl phosphate synthetase. These research activities overlap and integrate in many ways because the metabolic phenomena involved are closely related and also because the experimental approaches used in this work are similar. The proposed research includes studies on the active sites of enzymes and on their chemical, catalytic and regulatory properties. Emphasis is given to the development of potent and selective inhibitors that can be used in vivo to probe metabolism. Analogs of substrates may serve as inhibitors which may be useful in studies of enzyme structure and mechanism, as model compounds in the investigation of metabolism, and also to achieve physiological effects that may be useful in therapy. Previously, enzyme-oriented studies of this type have led to the development of compounds that are active in vivo and of potential value in treatment. These compounds include buthionine sulfoximine, an inhibitor of gamma-glutamylcysteine synthetase which is currently planned for clinical trials, L-2-oxothiazolidine-4- carboxylate, an in vivo cysteine precursor, and glutathione mono ethyl ester, a compound useful for increasing glutathione levels of cells. In the further course of this work, additional insights will be sought about the relationships between enzyme-catalyzed reactions and physiological and pathological phenomena. The evidence that has thus far been achieved indicates that further studies on the modulation of glutathione metabolism may be a promising pathway of research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37DK012034-21
Application #
3482962
Study Section
Biochemistry Study Section (BIO)
Project Start
1977-09-01
Project End
1992-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
21
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Ye, G J; Breslow, E B; Meister, A et al. (1996) The amino acid sequence of rat kidney 5-oxo-L-prolinase determined by cDNA cloning. J Biol Chem 271:32293-300
Ikeda, Y; Fujii, J; Taniguchi, N et al. (1995) Expression of an active glycosylated human gamma-glutamyl transpeptidase mutant that lacks a membrane anchor domain. Proc Natl Acad Sci U S A 92:126-30
Meister, A (1995) Mitochondrial changes associated with glutathione deficiency. Biochim Biophys Acta 1271:35-42
Smith, T K; Meister, A (1995) Chemical modification of active site residues in gamma-glutamyl transpeptidase. Aspartate 422 and cysteine 453. J Biol Chem 270:12476-80
Huang, C S; He, W; Meister, A et al. (1995) Amino acid sequence of rat kidney glutathione synthetase. Proc Natl Acad Sci U S A 92:1232-6
Ikeda, Y; Fujii, J; Taniguchi, N et al. (1995) Human gamma-glutamyl transpeptidase mutants involving conserved aspartate residues and the unique cysteine residue of the light subunit. J Biol Chem 270:12471-5
Ikeda, Y; Fujii, J; Anderson, M E et al. (1995) Involvement of Ser-451 and Ser-452 in the catalysis of human gamma-glutamyl transpeptidase. J Biol Chem 270:22223-8
Smith, T K; Ikeda, Y; Fujii, J et al. (1995) Different sites of acivicin binding and inactivation of gamma-glutamyl transpeptidases. Proc Natl Acad Sci U S A 92:2360-4
Meister, A (1994) Glutathione, ascorbate, and cellular protection. Cancer Res 54:1969s-1975s
Smith, T K; Meister, A (1994) Active deglycosylated mammalian gamma-glutamyl transpeptidase. FASEB J 8:661-4

Showing the most recent 10 out of 46 publications